Table 2 Registered clinical trials on the prevention of diabetic vascular complications
Main ID | Country | Invention | Prevention | Status |
|---|---|---|---|---|
PRECIDENTD, NCT05390892 | United States | GLP-1 receptor agonist and/or SGLT2 inhibitor | Cardiovascular and diabetic kidney disease | Ongoing |
EUCTR2019-004772-19-DK | Denmark | Hjertemagnyl | Diabetic kidney disease | Ongoing |
CTRI/2015/01/005366 | India | Ayurvedic formulation | Diabetic vascular complications | Ongoing |
PRIORITY, NCT02040441/UCTR2012-000452-34-GB/DRKS00008801 | Multi-European countries | Spironolactone | Diabetic kidney disease | Completed |
NCT01725412 | Canada | Thiamine | Diabetic kidney disease | Unknown |
JPRN-UMIN000007718 | Japan | Antiplatelets (cilistazol) | Diabetic kidney disease | Unpublished |
JPRN-UMIN000002718 | Japan | Olmesartan | Diabetic kidney disease | Unknown |